These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9113444)

  • 1. Soluble fraction of class I human histocompatibility leukocyte antigens in the serum of liver transplant recipients.
    McMillan RW; Gelder FB; Zibari GB; Aultman DF; Adamashvili I; McDonald JC
    Clin Transplant; 1997 Apr; 11(2):98-103. PubMed ID: 9113444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble HLA class II concentrations in normal individuals and transplant recipients. Comparison with soluble HLA class I concentrations.
    McDonald JC; Adamashvili I; Hayes JM; Aultman DF; Rhynes VK; Gelder FB
    Transplantation; 1994 Dec; 58(11):1268-72. PubMed ID: 7992373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor human leukocyte antigens in the circulation of liver allograft recipients.
    Chauhan B; Mathew JM; Shenoy S; Flye MW; Howard T; Mohanakumar T
    Clin Transplant; 1995 Feb; 9(1):14-9. PubMed ID: 7742577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble HLA class I in the serum of transplant recipients.
    Rhynes VK; McDonald JC; Gelder FB; Aultman DF; Hayes JM; McMillan RW; Mancini MC
    Ann Surg; 1993 May; 217(5):485-9; discussion 489-91. PubMed ID: 8489311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen-G, a new parameter in the follow-up of liver transplantation.
    Baştürk B; Karakayali F; Emiroğlu R; Sözer O; Haberal A; Bal D; Haberal M
    Transplant Proc; 2006 Mar; 38(2):571-4. PubMed ID: 16549178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I; Höckerstedt K; Isoniemi H
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to HLA-E may account for the non-donor-specific anti-HLA class-Ia antibodies in renal and liver transplant recipients.
    Ravindranath MH; Pham T; Ozawa M; Terasaki PI
    Int Immunol; 2012 Jan; 24(1):43-57. PubMed ID: 22190577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS; Navarro VJ; Colombe BW; Daskalakis C; Herrine SK; Rossi S
    Liver Transpl; 2007 Oct; 13(10):1405-13. PubMed ID: 17902126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S
    J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-derived human leukocyte antigen class I proteins in the serum of heart transplant recipients.
    DeVito-Haynes LD; Jankowska-Gan E; Heisey D; Jutte NH; Balk AH; Weimar W; Claas FH; Warner TF; Mentzer RM; Love RB; Burlingham WJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1012-26. PubMed ID: 8913919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease.
    Kerman RH; Susskind B; Kerman D; Lam M; Gerolami K; Williams J; Kalish R; Campbell M; Katz S; Van Buren CT; Frazier H; Radovancevic B; Fife S; Kahan B
    J Heart Lung Transplant; 1998 Aug; 17(8):789-94. PubMed ID: 9730428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ; Rossi AF; Courtney M; Gelb BD
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V; Herrine S; Katopes C; Colombe B; Spain CV
    Liver Transpl; 2006 Apr; 12(4):652-8. PubMed ID: 16555339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.